ArticleThe Journal of international medical research2020

Survival analysis of afatinib versus erlotinib for individuals with advanced del19 lung adenocarcinoma with asymptomatic brain metastasis after pemetrexed-cisplatin chemotherapy: a retrospective study.

Ye Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.